Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer Based on High-Resolution Dynamic Immune Signature Analysis

NCT06448169 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT06448169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06448169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer Based on High-Resolution Dynamic Immune Signature Analysis
Lead sponsor
Shandong University
Phase
Observational
Overall status
Unknown status
Start date
May 30, 2024
Completion date
April 30, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neoadjuvant immunotherapy, sensitivity, triple negative breast cancer